Your browser doesn't support javascript.
loading
Graft Protective and Intercellular Immunomodulatory Effects by Adoptive Transfer of an Agonistic Anti-BTLA mAb (3C10) Induced CD4+CD25+ Regulatory T Cells in Murine Cardiac Allograft Transplant Model.
Masaoka, Hisanori; Yamamoto, Yasuto; Uchiyama, Masateru; Iguchi, Kazuhito; Nakamura, Masahiro; Yagita, Hideo; Imazuru, Tomohiro; Shimokawa, Tomoki.
Afiliación
  • Masaoka H; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
  • Yamamoto Y; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
  • Uchiyama M; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan. Electronic address: mautiya@yahoo.co.jp.
  • Iguchi K; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
  • Nakamura M; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
  • Yagita H; Department of Immunology, Juntendo University, Tokyo, Japan.
  • Imazuru T; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
  • Shimokawa T; Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan.
Transplant Proc ; 56(3): 692-700, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38360464
ABSTRACT

BACKGROUND:

We demonstrated that an agonistic anti-B and T lymphocyte attenuator antibody (3C10) prolonged cardiac survival by inducing regulatory T cells (Treg). However, the mechanisms of immune tolerance in the recipients remained unclear. In this study, we investigated the graft-protective and intercellular immunomodulatory effects of adoptive transfer (AT) of 3C10-induced Tregs in a murine cardiac allograft transplant model.

METHODS:

Thirty days after transplantation of a C57BL/6 heart into the primary 3C10-treated CBA recipients, splenic CD4+CD25+ cells from these recipients (3C10/AT group) or naïve CBA mice (no-treatment group) were adoptively transferred into secondary CBA recipients with a C57BL/6 heart. To confirm the requirement for 3C10-induced Tregs, we administered an anti-interleukin-2 receptor alpha antibody (PC-61) to secondary CBA recipients. Additionally, histologic and fluorescent staining, cell proliferation analysis, flow cytometry, and donor-specific antibody (DSA) measurements were performed.

RESULTS:

3C10/AT-treated CBA recipients resulted in significantly prolonged allograft survival (median survival time [MST], >50 days). Allografts displayed prolonged function with preservation of vessel structure by maintaining high numbers of splenic CD4+CD25+Foxp3+ Treg and intramyocardial CD4+Foxp3+ cells. DSA levels were suppressed in 3C10/AT-treated CBA recipients. Moreover, PC-61 administration resulted in a shorter MSTs of cardiac allograft survivals, a detrimental increase in DSA production, and enhanced expression of programmed cell death (PD)-1.

CONCLUSION:

AT of 3C10-induced Tregs may be a promising graft-protective strategy to prolong allograft survival and suppress DSA production, driven by the promotion of splenic and graft-infiltrating Tregs and collaboration with PD-1+ T cells and Treg.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Linfocitos T Reguladores / Traslado Adoptivo / Supervivencia de Injerto / Ratones Endogámicos CBA / Ratones Endogámicos C57BL Límite: Animals Idioma: En Revista: Transplant Proc Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Linfocitos T Reguladores / Traslado Adoptivo / Supervivencia de Injerto / Ratones Endogámicos CBA / Ratones Endogámicos C57BL Límite: Animals Idioma: En Revista: Transplant Proc Año: 2024 Tipo del documento: Article País de afiliación: Japón
...